Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
19.23
-0.06 (-0.31%)
At close: Apr 10, 2026, 4:00 PM EDT
18.96
-0.27 (-1.40%)
After-hours: Apr 10, 2026, 5:50 PM EDT
Denali Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$34.27
Upside
+78.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy Maintains $32 → $34 | Buy | Maintains | $32 → $34 | +76.81% | Apr 7, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $42 | Buy | Maintains | $40 → $42 | +118.41% | Mar 26, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +108.01% | Mar 26, 2026 |
| Stifel | Stifel | Strong Buy Maintains $34 → $41 | Strong Buy | Maintains | $34 → $41 | +113.21% | Mar 26, 2026 |
| Baird | Baird | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +66.41% | Mar 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $42 | Strong Buy | Maintains | $32 → $42 | +118.41% | Mar 26, 2026 |
| BTIG | BTIG | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +97.61% | Mar 25, 2026 |
| BTIG | BTIG | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | +87.21% | Mar 2, 2026 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 24, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +66.41% | Feb 6, 2026 |
| UBS | UBS | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +30.01% | Jan 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $31 → $30 | Buy | Maintains | $31 → $30 | +56.01% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Maintains $30 → $31 | Buy | Maintains | $30 → $31 | +61.21% | Dec 5, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +66.41% | Dec 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +35.21% | Nov 4, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.